TITLE:
Quantifying the Effect of Metformin 1000 mg/day in Japanese Patients with Type 2 Diabetes
AUTHORS:
Katsunori Suzuki, Taishi Yoshioka, Yoko Wakui
KEYWORDS:
High-Dose Metformin, Type 2 Diabetes, HbA1c
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.5 No.15,
August
7,
2014
ABSTRACT: Objective: To
examine the effect of high-dose metformin on glucose metabolism in Japanese patients
with type 2 diabetes. Method: A total of 144 patients with type 2 diabetes who
could be followed up for 6 months after their dose of metformin was increased
to 1000 mg/day (from 750 mg/day or less) were examined. The dose of metformin
was increased from 750 mg/day in 70 subjects (250-mg dose increase) and from
500 mg/day in 74 subjects (500-mg dose increase). Results: After the dose
increased to 1000 mg/day, HbA1c was significantly decreased by 0.65% ± 0.7%, 0.42% ± 0.5%, and 0.87% ± 0.7% in all
subjects, the 250-mg dose increase group, and the 500-mg dose increase group,
respectively. No significant change was observed in weight. Analysis by BMI
(2 and ≥25 kg/m2) revealed a comparable
significant decrease in HbA1c in all subjects, the 250-mg dose increase group,
and the 500-mg dose increase group. Analysis by duration of diabetes showed a
significant decrease in HbA1c regardless of the duration. Conclusion:
Increasing the metformin dose to 1000 mg/day showed a significant
antihyperglycemic effect over 6 months in Japanese patients with type 2
diabetes. Blood glucose improved regardless of the duration of diabetes or the
presence or absence of obesity. Overall tolerability was favorable.